The Swiss government wants to put safety labels on packages of medical products in an effort to boost its fight against counterfeit drugs.
This content was published on
1 minute
swissinfo.ch and agencies/urs
The interior ministry says a tag guaranteeing product authenticity – coupled with more national and international information sharing plus covert criminal investigations – will help safeguard public health. The proposal also seeks to limit drug imports private individuals.
“Counterfeit products and illegally traded drugs or medical products can be a serious health hazard,” said the ministry in a statement on Wednesday.
The legal amendment, still to be discussed by parliament, is in line with the Medicrime ConventionExternal link of the Council of Europe, signed by Switzerland in 2011.
The growing international trade in counterfeit medication, often over the internet, has also affected Switzerland. According to the interior ministry, an estimated 20,000 shipments of fake drugs arrive in the country every year.
Switzerland has recently adapted its medication legislation, but further amendments are needed to comply with the European convention.
The Geneva-based World Health Organization says counterfeit drugs account for just 1% of the market in industrialised countries, but they are a serious health hazard in some countries in southeast Asia, Africa and Latin America.
Popular Stories
More
Swiss Politics
Why cars still reign supreme in ‘rail-nation’ Switzerland
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss fight internet supply of illegal medicines
This content was published on
The campaign, involving more than 20 countries, resulted in a series of arrests and the seizure of thousands of potentially harmful medical products, according to Interpol. “The problem of supply of counterfeit and illegal medicines is a global problem and everywhere around the world this is a growing trend,” Ruth Mosimann, head of the Control…
This content was published on
“In the 80 countries we work in, we are dealing every day with individuals and entire families who get into debt to buy fake medicines. And the terrible thing is that often these medicines damage their health or kill them, without them even realising it,” says Guillaume Schmidt, a pharmacist who works for the Swiss…
This content was published on
“The phenomenon of fake drugs reached catastrophic dimensions a long time ago for the inhabitants of the world’s poorest regions,” said Claude Rohrbasser, retired head of industrial technology at the College of Engineering and Architecture of Fribourg. “So several years ago we said to ourselves that with our knowledge and technological possibilities, we could do…
This content was published on
In mid-February the US Food and Drugs Administration (FDA) announced that several oncologists in California, Texas and Illinois had received what appeared to be a fake replacement for the cancer drug Avastin from their suppliers. Unlike the genuine article produced by Roche subsidiary Genentech, the false medication did not contain the active ingredient Bevacizumab. According…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.